£113.94

Springer Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£114 today · previous high £114 · all-time low £113

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£113.94 £112.96 £113.17 £113.39 £113.60 £113.82 £114.03 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
67 days 23 days · current 0 17 34 50 67 £113 £114 Days at Price

Price Analysis

Most common price: £113 (67 days, 74.4%)

Price range: £113 - £114

Price levels: 2 different prices over 90 days

Description

Exciting advances are occurring in the understanding of the molecular pathogenesis of squamous head and neck cancers. Epidemiology, staging and screening, as well as premalignancy, chemoprevention and the molecular biology of head and neck cancer, lay the groundwork for the understanding of the clinical chapters that follow. Controversial treatments will be compared to the standard management of patient care. Therapy chapters are divided into stage or category specific (resectable advanced, unresectable advanced or metastatic) problems, allowing the reader to review the current standards and options for patient types or specific patients easily. Considerations of supportive care, late toxicities and quality of life, often overlooked are reviewed in detail. This is a comprehensive summary of the current state of the art research and treatment.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
08 December 2010
Listed Since
14 June 2010

Barcode

No barcode data available

Similar Products You Might Like

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
87% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.64 18 May 2026
HPV Infection in Head and Neck Cancer: 206 (Recent Results in Cancer Research, 206)
87% match

HPV Infection in Head and Neck Cancer: 206 (Recent Results in Cancer Research, 206)

Springer

£73.10 18 May 2026
Head and Neck Cancer Imaging (Medical Radiology)
87% match

Head and Neck Cancer Imaging (Medical Radiology)

Springer

£111.72 17 May 2026
Radiation Therapy for Head and Neck Cancers: A Case-Based Review
86% match

Radiation Therapy for Head and Neck Cancers: A Case-Based Review

Springer

£68.90 17 May 2026
Oral Cancer: Diagnosis and Therapy
86% match

Oral Cancer: Diagnosis and Therapy

Springer

£94.43 17 May 2026
Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer
85% match

Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer

Springer

£108.91 18 May 2026
Oral Cancer Metastasis
84% match

Oral Cancer Metastasis

Springer

£107.98 18 May 2026
Neuroendocrine and Oral Cancers: An Interdisciplinary Approach: 14 (Interdisciplinary Cancer Research, 14)
84% match

Neuroendocrine and Oral Cancers: An Interdisciplinary Approach: 14 (Interdisciplinary Cancer Research, 14)

Springer

£141.08 15 May 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
83% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£148.53 18 May 2026
Hilar Cholangiocarcinoma
83% match

Hilar Cholangiocarcinoma

Springer

£81.58 18 May 2026
Neuroendocrine and Oral Cancers: An Interdisciplinary Approach (Interdisciplinary Cancer Research, 14)
83% match

Neuroendocrine and Oral Cancers: An Interdisciplinary Approach (Interdisciplinary Cancer Research, 14)

Springer

£174.99 11 May 2026
Squamous cell Carcinoma: Molecular Therapeutic Targets
82% match

Squamous cell Carcinoma: Molecular Therapeutic Targets

Springer

£107.98 18 May 2026
Biological Basis of Geriatric Oncology: 124 (Cancer Treatment and Research, 124)
82% match

Biological Basis of Geriatric Oncology: 124 (Cancer Treatment and Research, 124)

Springer

£107.98 18 May 2026
Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer (Comprehensive Gynecology and Obstetrics)
82% match

Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer (Comprehensive Gynecology and Obstetrics)

Springer

£71.08 16 May 2026
Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)
82% match

Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)

Springer

£77.79 11 May 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
82% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£163.15 18 May 2026
Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)
81% match

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

Springer

£77.37 18 May 2026
Advances in Endophytic Research
81% match

Advances in Endophytic Research

Springer

£146.73 18 May 2026
Development of Oral Cancer: Risk Factors and Prevention Strategies
81% match

Development of Oral Cancer: Risk Factors and Prevention Strategies

Springer

£81.54 11 May 2026
Gynecologic Oncology: Controversies and New Developments: 70 (Cancer Treatment and Research, 70)
81% match

Gynecologic Oncology: Controversies and New Developments: 70 (Cancer Treatment and Research, 70)

Springer

£113.76 18 May 2026
Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)
81% match

Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)

Springer

£113.76 11 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
81% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 17 May 2026
Central Nervous System Metastasis, the Biological Basis and Clinical Considerations: 18 (Cancer Metastasis - Biology and Treatment, 18)
81% match

Central Nervous System Metastasis, the Biological Basis and Clinical Considerations: 18 (Cancer Metastasis - Biology and Treatment, 18)

Springer

£107.72 18 May 2026
Hematopathology in Oncology: 121 (Cancer Treatment and Research, 121)
81% match

Hematopathology in Oncology: 121 (Cancer Treatment and Research, 121)

Springer

£73.85 18 May 2026